Google TrendGME (1000+) — GameStop Stock Hits a New 52-Week High: What's Going On?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Improvement of Pharmacoki" (30 stories)

Top Headline Story

Discovery of potent kinase inhibitors with improved pharmacokinetics and safety potentials through structural optimization of dasatinib
Lead StoryNaturegeneral
Apr 10

Discovery of potent kinase inhibitors with improved pharmacokinetics and safety potentials through structural optimization of dasatinib

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5kRG0xUThUaWQwOWRyanpDZGdUR2lWZU5uWUtZZ19ENlQ5NGRXcExXM0VNdXhFeElTX2tFVXBBdDJYSG93R0lsTmdOQnZDWlhUMWlOM1UzTFhrUVoyZFRR?oc=5" target="_blank">Discovery of potent kinase inhibitors with improved pharmacokinetics and safety potentials through structural optimization of dasatinib</a>  <font color="#6f6f6f">Nature</font>

Real-time search volume
1000+16m ago

gme

GameStop Stock Hits a New 52-Week High: What's Going On?

200+16m ago

pope francis

The Myth of St. Francis

500+26m ago

nicolò tresoldi

Nicolò Tresoldi, chi è l'attaccante del Bruges che spaventa l'Inter in Champions League

1000+26m ago

michael olise

The Ballon d’Or doesn’t capture football’s wonder – Michael Olise is proof | Zito Madu

Search Results for "Improvement of Pharmacoki"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
An improved pharmacokinetics parameter to measure dose proportionality
The Pharmaceutical Journalgeneral

An improved pharmacokinetics parameter to measure dose proportionality

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxOV2xRNkoxRmc2U3MzYmx2Y0ZHRjZPMDF1aHQ3LVQwZkR0M3JMZF80QkpLdWtONFlFanN6UVVrNldPVktLRFJyd29jcEVVcUN6LUtJcU1VcFhsaHh1YzU5a2N0YzgwbGJza3ZUVUdENThfaktBOWZ0cUhCd0EtUWw0QWlKTkhjWXU0NjYxMWJPd1c0UVZzQnhyMmk4WTFuV0xLdFdJelh4MzhjemV6Y1ZZTVBfeGo4b19WVUZabS1n?oc=5" target="_blank">An improved pharmacokinetics parameter to measure dose proportionality</a>  <font color="#6f6f6f">The Pharmaceutical Journal</font>

PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials | Scientific Reports
Naturegeneral

PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE16WDg5T3VzN2VPWkFXT2NGN1RTTXk4TXZoUDNXYVBELWF0blgyMGFoYUVkSndyMmc5QnJBVEt3QTgxSTI1bnJVcDctNG9RSER1Q2h6czNMclc5bElZdGhF?oc=5" target="_blank">PEGylated liposomes enhance the pharmacokinetics, biodistribution, anticancer efficacy, and safety of Kaempferol, a phytomolecule enrolled in clinical trials | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin
Frontiersgeneral

Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOdURaSWFrVXFnOURyMlNRWmE2QVdMSVN0NUoteGRkRkM0aEZteGMzR2tBampfY1p3R1hIYUpWZFFkNktIQlZpZnU2SlVaN2h0eWFRQ3BtdHlxZ0s5SWpRUlFFVGRUUzEzbC0tUzdvYVJsSzllUmxpaW9tSllDZTFtMm1IeTduTkNIMWtKN2w3WWJTbm8x?oc=5" target="_blank">Improvement of solubility and pharmacokinetic profile of hepatoprotector icariin through complexation with HP-γ-cyclodextrin</a>  <font color="#6f6f6f">Frontiers</font>

Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies
Naturegeneral

Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1pTUQyS3pyLXBoZERlMXpHMU1QNnZ2RW1YYXNYUGVlQXZSMVo0VXRia0hQQTkta2wtaXo2Z0IwM203Yjc2YlRoUmRGRm56UXI2M2pvU1VBck56d2pkQndZ?oc=5" target="_blank">Reduced relapse rate and improved GVHD/relapse free survival (GRFS) with pharmacokinetics-guided busulfan conditioning regimen for allogeneic stem cell transplantation in adult patients with myeloid hematologic malignancies</a>  <font color="#6f6f6f">Nature</font>

Solid Dose Form of Metformin with Ethyl Eicosapentaenoic Acid Does Not Improve Metformin Plasma Availability
SCIRP Open Accesstech

Solid Dose Form of Metformin with Ethyl Eicosapentaenoic Acid Does Not Improve Metformin Plasma Availability

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5PNlQ1NFJQc1hhM1BvOU9VY0xNb3lBamx4OVp6aXpfaGRPREJPOEduYThPODVOY29zT0UwOXJoMXpEc3gzbVVaUFFZYjJTTnRIX3dRbDd4aEJoQlhUaVU0dU82ZmM4em44bUIzcg?oc=5" target="_blank">Solid Dose Form of Metformin with Ethyl Eicosapentaenoic Acid Does Not Improve Metformin Plasma Availability</a>  <font color="#6f6f6f">SCIRP Open Access</font>

Incorporating Nonlinear Kinetics to Improve the Predictive Performance of Population Pharmacokinetic Models for Ciclosporin in Adult Renal Transplant Recipients: A Comparison of Modelling Strategies
medRxivgeneral

Incorporating Nonlinear Kinetics to Improve the Predictive Performance of Population Pharmacokinetic Models for Ciclosporin in Adult Renal Transplant Recipients: A Comparison of Modelling Strategies

<a href="https://news.google.com/rss/articles/CBMickFVX3lxTE9acGNkX2lPVEtlVWh2ang2TENwNUtZM0RfcjMxdnYyMVJ4ZzlHNGVRSTI2OU02dGI1QUpuSldqdWtzZjRhNDlmMXI0d1pSb3J4eWRoSWZoQTFBczlqOXJNS1JKSmU4dG11cFlwa3F3V09HUQ?oc=5" target="_blank">Incorporating Nonlinear Kinetics to Improve the Predictive Performance of Population Pharmacokinetic Models for Ciclosporin in Adult Renal Transplant Recipients: A Comparison of Modelling Strategies</a>  <font color="#6f6f6f">medRxiv</font>

Improving the pharmacokinetics, biodistribution and plasma stability of monobodies
Frontiersgeneral

Improving the pharmacokinetics, biodistribution and plasma stability of monobodies

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxQeUpqN2ttMnlLVzlsRHpVenotbEpHMFlNdzFTSzc4X3lUbkY5VTJaRzhVdEQ0V2JEU3VEQ0ZLX3hXNTYtZExpUDd4dmtoS3NpRFFZWmVzY3B6WndFRHZnVnBTa0M3d01vUDZhOW1kZGd2LWRqUGpaNHN0QnNQdjdrWHVfYWk4aDR2cllSeU5tdFNxNUtm?oc=5" target="_blank">Improving the pharmacokinetics, biodistribution and plasma stability of monobodies</a>  <font color="#6f6f6f">Frontiers</font>

Liposomal encapsulation of L-arginine and L-citrulline enhances pharmacokinetics and therapeutic effects in a model of preeclampsia and fetal growth restriction
Naturegeneral

Liposomal encapsulation of L-arginine and L-citrulline enhances pharmacokinetics and therapeutic effects in a model of preeclampsia and fetal growth restriction

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFAzTkw4bFFmQVJ5eEFFa3M0bzBIbVFQaGtxSXhpT21fUmRyckRmZUE5QjNpbUJBdnh0SXRxQ09aUDB4X2kyRVBTZThyWkRfNDZ2UGtkUnAzN2xUZ1QxRTRv?oc=5" target="_blank">Liposomal encapsulation of L-arginine and L-citrulline enhances pharmacokinetics and therapeutic effects in a model of preeclampsia and fetal growth restriction</a>  <font color="#6f6f6f">Nature</font>

Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery
Frontiersgeneral

Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxOOTQxSjdSOHREUGFxV05sQWZkeEtfNmJkbk9BUjRKQnVzMFpkbWxyUXg2V1p4TlM4Nm1nRHdXMC1IYXRmZm1tNXg0NzBiY3UyTTVnTTJWVTBWeUhzUDF4UksyNURHYzlSUmVKT0ZvS0NvVjJVS29CaVNmSlBRV0tOTFB6cndtYmtFbmhITmlvckxHZw?oc=5" target="_blank">Pharmacokinetic Aspects of Nanoparticle-in-Matrix Drug Delivery Systems for Oral/Buccal Delivery</a>  <font color="#6f6f6f">Frontiers</font>

Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage
Frontierspolitics

Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxOdUtOUTJsV0FlZnVXb2otcUwzNGRuNkJlSm1zaEtiYmUwTWJYY1ZCZ3BhS2kzWkZ3eDFnQUxZRVpTVnpFTUVhSVFSbkp3LUtOTGVTTkVhVUt0d1VwcUpBY3hndFpoMTk0dnIxU3RKTkxNVDJmay1Odnp3dW5RTGE2ZkxzRmVFeHpwQmxZeVpJVzdGekRVYnc?oc=5" target="_blank">Oral delivery of peptides and proteins: pharmacokinetic boundaries, negative selection, and route triage</a>  <font color="#6f6f6f">Frontiers</font>

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo
Naturetech

Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9lMFdJUkg4OTdQSk5kcVl3NUhlbnB1SENPaGF3cW1kNW5oOW5OYTRjeHg3QjJRVGVhQzFHSzZpOXZVcW1jUEp0WDRPT0IxUV91ZktUUkU1ekdwNFIwREY4?oc=5" target="_blank">Improvement of Pharmacokinetic Profile of TRAIL via Trimer-Tag Enhances its Antitumor Activity in vivo</a>  <font color="#6f6f6f">Nature</font>

Enhancing antibiotic therapy through comprehensive pharmacokinetic/pharmacodynamic principles
Frontiersgeneral

Enhancing antibiotic therapy through comprehensive pharmacokinetic/pharmacodynamic principles

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxONlBtWXA3VzVzRXQzY3pxc2FldmU4a2N6Y051N1BCX0w5NUNLOERzeDV1R01vRS1FeE41ZlNMa0drRnhobnpLNWdwb2pURnBDVnlKaGhkbGR6Z05FekRnc2IwdUJQUURqSUd1V1hwYnVaeVlENTdpUHRlU2NzREhoeEJicWdQRkdscG94V3NGOFM5R0toZTlaQjlSYkpZN1duS1ZkUkNMRDZodlA1bEdlaUZrQQ?oc=5" target="_blank">Enhancing antibiotic therapy through comprehensive pharmacokinetic/pharmacodynamic principles</a>  <font color="#6f6f6f">Frontiers</font>

inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir
Naturegeneral

inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1GRWE2ZG5UQXhpaUkxRnBzNWlOcWdoTDI4VzlVbS1aRENvT2t6OFduVWxiUzJSVDg4dUs5ZEpGU2pRNUh3VXlGdkxxd2hLbHNySmN5TlR5aHhNcjR0MThR?oc=5" target="_blank">inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir</a>  <font color="#6f6f6f">Nature</font>

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2
Naturetech

DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE94amNBUG81Wk5KLWdDSlJPQkk2YlZPYUxacGlSYkV3cU9XU1BFREVqd0VFeFRLbUY3N0ludV90blVhOW9WNjhCaG5ZYmJBOXo4SEJTWnlQcE9yMnFOZ2dr?oc=5" target="_blank">DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2</a>  <font color="#6f6f6f">Nature</font>

Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation protein
Naturegeneral

Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation protein

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1lZWgtZS1HUU9VZlVNeWpaVHd2NmU5N0FoZnhBYWswQlhYdUp4TWwxMjItZUhyenZ6UzFxQXE5REJ3V3VnMkJWQVlXTGU1MTNqeVJfdnpFdUhnWXM0d2pV?oc=5" target="_blank">Increased imaging ligand hydrophilicity and improved pharmacokinetic properties provides enhanced in vivo targeting of fibroblast activation protein</a>  <font color="#6f6f6f">Nature</font>

Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects
Naturescience

Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5jLUVPdklTTlk2MzhLcTVkWC15YlNMOExTNTVmZUdTWnktX3BLUjRhTTFHaFF1OHA0WTRhM3c5NlhNeHNnZ3BBMU5pcUk4U2dpNmt0ZDF5NV9MNlNCcGJJ?oc=5" target="_blank">Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects</a>  <font color="#6f6f6f">Nature</font>

Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients
Naturegeneral

Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5pLXNNTEs1M000RTlHVjh3UjdQZ2ZrRGNKaXEwTmFEbkdpVlhsWUp6MTFpel8tWXVaNVozRmNXeVFtQ3duUlJBRXhRNkpERVdpalY4QTZ5akkyNzhuQUdr?oc=5" target="_blank">Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients</a>  <font color="#6f6f6f">Nature</font>

Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges
Naturegeneral

Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE85UTJWM3hRclJWY1JqOVhFNDd6VkppYTBtTkJnY2FPbHFQZnFSc1FmQ3VJbDNMREVXTGNvamh5Zmx2eW5CWGt4c1Y2Zkk0NVNUdmhHaU5nOFdraC00MUVZ?oc=5" target="_blank">Pharmacokinetic characteristics of mesenchymal stem cells in translational challenges</a>  <font color="#6f6f6f">Nature</font>

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance
Naturegeneral

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5ZSEhKOUpSck5tYWpvX1hDcUJpMTZfREJ2dm04NDVfaUdYbVlqa19tc2hTT3k0R2dHUDJSZ2V5UGN4Yl9EaDBZTEtMRVBsVHZSVFN0eUpVZDRPTld0WUZN?oc=5" target="_blank">In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance</a>  <font color="#6f6f6f">Nature</font>

Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study | Scientific Reports
Naturetech

Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBmRGFnT1dWcEJwUUdKZVJwTGpxSWlxTnRJbnN4S0ExeHUwYS1PRUMwaFA4blhXMTRPMEw0UXZMLVU5N0NzYjFUQ1dVVnFEamREMHVwZ1VzbGtHcTRPR2VV?oc=5" target="_blank">Improved therapeutic potential of tapentadol employing cationic exchange resins as carriers in neuropathic pain: evidence from pharmacokinetic and pharmacodynamics study | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Ocular Pharmacokinetics of ISV-215 (Bimatoprost 0.03%) Formulated in a DuraSite Delivery System Compared to Lumigan in Rabbits | IOVS | ARVO Journals
IOVS Journalgeneral

Ocular Pharmacokinetics of ISV-215 (Bimatoprost 0.03%) Formulated in a DuraSite Delivery System Compared to Lumigan in Rabbits | IOVS | ARVO Journals

<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9iUnRURGlWOGIzaDJ5SjNXSHExMTJGVWdVWmxXdENuYlRIcDBGWUtaYTRUMFd4UEsxcnNJOGpHNFc3V3poYzRVbXhEZC1POGk4YUFLbXN5bE5NbG5BQW00MWctMXcyMmIyS1dsRg?oc=5" target="_blank">Ocular Pharmacokinetics of ISV-215 (Bimatoprost 0.03%) Formulated in a DuraSite Delivery System Compared to Lumigan in Rabbits | IOVS | ARVO Journals</a>  <font color="#6f6f6f">IOVS Journal</font>

Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations
Naturetech

Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE85TVM1bldlOG11Nm1VNUdCMEs2ZmRpV2h1TXpPYkRYLWFjcmhuUUFQNkNOa2x5SFpsWWRCS2ltMHIyT0phTl80VFBVbFJlajVsV3VhOUMwMzk4a0FXc3Fn?oc=5" target="_blank">Development of extended pharmacokinetic models for propofol based on measured blood and brain concentrations</a>  <font color="#6f6f6f">Nature</font>

Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs) | Scientific Reports
Naturegeneral

Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs) | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE15YWNfbG9idV9IZTdEVVdZREdkSVhHNWlrbC1jcmxfbEdSaFZGclhiVnB5clpYQUpwc2pVNGlTZDhwOXlNdjJScVV2M0dXODRPOHd0LUhLazVDeE9jYkNB?oc=5" target="_blank">Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs) | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential
ScienceDirect.comscience

The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential

<a href="https://news.google.com/rss/articles/CBMie0FVX3lxTE9SbVBFRHJUUkxyMWtUR0FNd2NRbFQ1d3NKODd5UFJ0SE5jcEJnSktwd2NMb1hpRnZGZjdBUW5pNnBudUV2Zm12emRnWHE5d2xSSVh6MF95eExCblBrX1VJQVhMaWIzMk8wRHdTOE5BWnc0Z0V2YjE2T1czYw?oc=5" target="_blank">The science of resveratrol, formulation, pharmacokinetic barriers and its chemotherapeutic potential</a>  <font color="#6f6f6f">ScienceDirect.com</font>

Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing
Naturegeneral

Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1hdFFSSXJsN0tfVjBWNjNjcTdNTWFoWWxWWnV6ektmSXYyR0pxR0lhUE9mMTlDZGZVYXB2MGw4eEk1enU2djlKM3pjV3V6LTJEZkhaUG4tNlVHbGNBd1Rv?oc=5" target="_blank">Glyco-engineered Long Acting FGF21 Variant with Optimal Pharmaceutical and Pharmacokinetic Properties to Enable Weekly to Twice Monthly Subcutaneous Dosing</a>  <font color="#6f6f6f">Nature</font>

Engineering biopharmaceutical formulations to improve diabetes management
Science | AAASgeneral

Engineering biopharmaceutical formulations to improve diabetes management

<a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5jdG4zNDEtMUFEczY1OW1TRkpPOHVlYjlIYUNtUjJ1eEhRXzlaR3RfSmN2LUxzOUo4NGdLelQyM3ZmblNlckdNZTV4NHFNb1NHNDhUOTlxOXpIWno3aWtlZ1A0eWMzemM?oc=5" target="_blank">Engineering biopharmaceutical formulations to improve diabetes management</a>  <font color="#6f6f6f">Science | AAAS</font>

FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing
Naturetech

FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE55RHdSaXFZTi1qUmVYTlA1N1dkU01QV0FqZzdKUHVNaUlEMzFQZUY1dTMxZzRENFp2dFFSMG5mLTJGWG5XZzJEcndDSV9CV3Bxd19rOUZDYw?oc=5" target="_blank">FV-162 is a novel, orally bioavailable, irreversible proteasome inhibitor with improved pharmacokinetics displaying preclinical efficacy with continuous daily dosing</a>  <font color="#6f6f6f">Nature</font>

Preparation and pharmacokinetic study of mebendazole complex with HP-beta-cyclodextrin
Frontiersgeneral

Preparation and pharmacokinetic study of mebendazole complex with HP-beta-cyclodextrin

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQVjllbVVBWWwtMnBBSXl3V01BZlVyaDQxUkhITmtNbXRmOTA2LXJ1YW0tam9zVkZZZjNfaWVNSC1VY3hmSThNeEFTeERmQ1YwQ253Zy1IVC01cTlQWDJZbnByWmNWN3FDYUdUR19CNERyT1dDWXNCXzZZSFdPTDl4aEFXby0wa1hKY053V2lFNlRQdUZ0ZDRiaF9Jano?oc=5" target="_blank">Preparation and pharmacokinetic study of mebendazole complex with HP-beta-cyclodextrin</a>  <font color="#6f6f6f">Frontiers</font>

ADME/Pharmacokinetic Studies from Serum and Plasma: Improvements in Sample Preparation and LC–MS Analysis of Therapeutic Oligonucleotides
Spectroscopy Onlinegeneral

ADME/Pharmacokinetic Studies from Serum and Plasma: Improvements in Sample Preparation and LC–MS Analysis of Therapeutic Oligonucleotides

<a href="https://news.google.com/rss/articles/CBMi1wFBVV95cUxOUHpJQTNMbGtqSXVPVHNBZFpvRHNzVDR2cF9nSnJJdUtyaU1WN2JFSENyTURleUd4SGRDdmlxT01OQ2FyUlF4Rm5BN0NRU0NtWXNuYzFLZ24walRNWGJaWVhtMVczTS1Xd0pPNTNocmw5MDc4eks1NC1QQVhIQW1tSVlidGF5LVpOVDRLM21wZFJpZWgtVk92VHBtbGN3eVdoM3djd1lNYmVFNWJTME9UaHp5eW9hcXNZbzVJZFhvMWt4aVcyQmF6QzVsakpZYjViYTZKMjhIOA?oc=5" target="_blank">ADME/Pharmacokinetic Studies from Serum and Plasma: Improvements in Sample Preparation and LC–MS Analysis of Therapeutic Oligonucleotides</a>  <font color="#6f6f6f">Spectroscopy Online</font>

"Improvement of Pharmacoki" — Live Google News Trends & Headlines